CVI Holdings’s Imunon IMNN Stock Holding History

CVI Holdings’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,727	Closed	-$466K	–	804
2021 Q1	$466K	Buy	+1,727	New	+$580K	0.03%	378
2020 Q2	–	Sell	-5,822	Closed	-$1.03M	–	72
2020 Q1	$1.03M	Buy	+5,822	New	+$1.46M	3.62%	8

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CVI Holdings's IMNN Position: Q2 2021 in Review

CVI Holdings sold out of Imunon (IMNN) in Q2 2021, closing a stake of 1,727 shares — an estimated $466K sold.

CVI Holdings first reported a position in IMNN in Q1 2020 and held it in 2 quarters. The position peaked at $1.03M in Q1 2020. 37 funds tracked by Wall St. Rank hold IMNN as of Q2 2021.

CVI Holdings reported no remaining Imunon position as of Q2 2021 after selling out during the quarter.
CVI Holdings sold 1,727 Imunon shares in Q2 2021, an estimated $466K.
CVI Holdings first reported a position in Imunon in Q1 2020 and held it in 2 quarters.
CVI Holdings's Imunon position peaked at $1.03M in Q1 2020.
37 funds tracked by Wall St. Rank held Imunon as of Q2 2021.

Based on CVI Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.